chartexchange

Prelude Therapeutics to Participate in the Chardan Healthcare Conference

GlobeNewswire Inc. | Oct 16, 2026 4:01 PM EDT

WILMINGTON, Del., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Chardan Healthcare Conference taking place in New York City on October 20, 2026.

Read original article